Ralf Nauen
	
			
 Ralf Nauen
						
	
	Bayer CropScience Aktiengesellschaft
	
	BCS AG-R-I-BI-PPS-RM
	
	Monheim
	
	Germany
	40789
	
	Papers:
	0931 
	Toxicodynamic consequences of selected target site mutations and implications for resistance management 
	


